Vita34 ApS: Financial statements 2014
CVR: 27511759
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Vita34 ApS (CVR 27511759) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 5,214,601 and a net result of DKK 1,386,987 compared with DKK 538,791 the year before. That is an increase of 3.4% compared with the year before. The profit margin was 26.6%. Equity in the 2014 report amounted to DKK 4,119,093. The solvency ratio was 10.6%.
- Revenue
- DKK 5,214,601
- Gross Profit
- DKK 5,739,210
- Profit/Loss
- DKK 1,386,987
- Equity
- DKK 4,119,093
- Total Assets
- DKK 38,750,023
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 5.2 mio. | 5.7 mio. | 1.4 mio. | 4.1 mio. | - |
| 2013 | 5 mio. | 4.5 mio. | 539 t. | 2.7 mio. | - |
| 2012 | 5.3 mio. | 4.6 mio. | 930 t. | 2.2 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
Vita34 ApS has published its annual report for 2013. Revenue came to DKK 5,043,717, and the net result was DKK 538,791.
About Vita34 ApS
Vita34 ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2004. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named StemCare ApS and BIOBANK DANMARK ApS. The management consists of Marion Bartel and Vivien Weise. The company is owned by FamiCord AG. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 3,842,095 and a net result of DKK 1,034,065 compared with DKK 1,030,138 the year before. Equity in the 2025 report amounted to DKK 5,982,880.